阿尔茨海默病的磁共振成像：从诊断到治疗评估。
Magnetic resonance imaging of Alzheimer's disease: from diagnosis to therapeutic evaluation.
机构信息
Beijing Military General Hospital, Beijing, China.
出版信息
Chin J Integr Med. 2010 Jun;16(3):276-82. doi: 10.1007/s11655-010-0276-8. Epub 2010 Aug 8.
PMID:20694785
Abstract
Alzheimer's disease (AD) is a devastating late-life dementia that produces progressive loss of memory and mental faculties in elderly people. It is important to identify the earliest evidence of AD and to monitor the development of this disease for us to make positive response to its management. Magnetic resonance imaging (MRI) is powerful to image the tissue or organ without damnification. MRI can be employed to diagnose the early AD development and monitor the key biomarker development in AD. MRI may be helpful not only in diagnosing early AD, but also in evaluating its development. This article reviews the progress of MRI on the diagnosis and detection of AD, and makes comments on its therapeutic application.
摘要
阿尔茨海默病（AD）是一种破坏性的老年痴呆症，会导致老年人记忆力和智力逐渐丧失。重要的是要识别 AD 的最早证据，并监测这种疾病的发展，以便我们对其进行积极的管理。磁共振成像（MRI）是一种强大的无损伤成像技术。MRI 可用于诊断早期 AD 发展并监测 AD 中的关键生物标志物发展。MRI 不仅有助于诊断早期 AD，还有助于评估其发展。本文综述了 MRI 在 AD 诊断和检测方面的研究进展，并对其治疗应用进行了评价。
相似文献
1
Magnetic resonance imaging of Alzheimer's disease: from diagnosis to therapeutic evaluation.
Chin J Integr Med. 2010 Jun;16(3):276-82. doi: 10.1007/s11655-010-0276-8. Epub 2010 Aug 8.
2
Magnetic resonance imaging based clinical research in Alzheimer's disease.
J Alzheimers Dis. 2012;31 Suppl 3:S5-18. doi: 10.3233/JAD-2011-111292.
3
MRI and CSF studies in the early diagnosis of Alzheimer's disease.
J Intern Med. 2004 Sep;256(3):205-23. doi: 10.1111/j.1365-2796.2004.01381.x.
4
Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Int J Geriatr Psychiatry. 2015 May;30(5):505-13. doi: 10.1002/gps.4173. Epub 2014 Jul 7.
5
[Diagnosis without therapy: early diagnosis of Alzheimer's disease in the stage of mild cognitive impairment].
Nervenarzt. 2011 Sep;82(9):1151-9. doi: 10.1007/s00115-010-3213-3.
6
Seven-Tesla MRI and neuroimaging biomarkers for Alzheimer's disease.
Neurosurg Focus. 2015 Nov;39(5):E4. doi: 10.3171/2015.9.FOCUS15326.
7
Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.
J Alzheimers Dis. 2015;48(2):425-32. doi: 10.3233/JAD-150229.
8
Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring.
Int J Mol Sci. 2021 Feb 20;22(4):2110. doi: 10.3390/ijms22042110.
9
Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications.
Neurodegener Dis Manag. 2014;4(1):73-81. doi: 10.2217/nmt.13.68.
10
In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET.
J Neural Transm (Vienna). 2002 May;109(5-6):837-55. doi: 10.1007/s007020200069.
引用本文的文献
1
Illuminating Neural Circuits in Alzheimer's Disease.
Neurosci Bull. 2021 Aug;37(8):1203-1217. doi: 10.1007/s12264-021-00716-6. Epub 2021 Jun 5.
2
Fabrication of deferasirox-decorated aptamer-targeted superparamagnetic iron oxide nanoparticles (SPION) as a therapeutic and magnetic resonance imaging agent in cancer therapy.
J Biol Inorg Chem. 2021 Feb;26(1):29-41. doi: 10.1007/s00775-020-01834-8. Epub 2020 Nov 6.
3
The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer's disease: protocol for a randomized controlled trial.
Trials. 2015 Apr 30;16:199. doi: 10.1186/s13063-015-0716-z.
本文引用的文献
1
Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice.
Int J Mol Sci. 2010 Jan 8;11(1):107-23. doi: 10.3390/ijms11010107.
2
A possible new diagnostic biomarker in early diagnosis of Alzheimer's disease.
Curr Alzheimer Res. 2009 Dec;6(6):519-24. doi: 10.2174/156720509790147160.
3
Minute effects of sex on the aging brain: a multisample magnetic resonance imaging study of healthy aging and Alzheimer's disease.
J Neurosci. 2009 Jul 8;29(27):8774-83. doi: 10.1523/JNEUROSCI.0115-09.2009.
4
Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study.
J Clin Psychopharmacol. 2009 Apr;29(2):147-56. doi: 10.1097/JCP.0b013e31819a8f2e.
5
Principal component analysis with pre-normalization improves the signal-to-noise ratio and image quality in positron emission tomography studies of amyloid deposits in Alzheimer's disease.
Phys Med Biol. 2009 Jun 7;54(11):3595-612. doi: 10.1088/0031-9155/54/11/021. Epub 2009 May 19.
6
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
Neuroimage. 2009 May 1;45(4):1107-16. doi: 10.1016/j.neuroimage.2008.12.072. Epub 2009 Jan 21.
7
Computed tomography of amyloid plaques in a mouse model of Alzheimer's disease using diffraction enhanced imaging.
Neuroimage. 2009 Jul 15;46(4):908-14. doi: 10.1016/j.neuroimage.2009.03.019. Epub 2009 Mar 19.
8
Role of huperzine a in the treatment of Alzheimer's disease.
Ann Pharmacother. 2009 Mar;43(3):514-8. doi: 10.1345/aph.1L402. Epub 2009 Feb 24.
9
Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease.
J Alzheimers Dis. 2009;16(2):351-62. doi: 10.3233/JAD-2009-0968.
10
Sodium MR imaging detection of mild Alzheimer disease: preliminary study.
AJNR Am J Neuroradiol. 2009 May;30(5):978-84. doi: 10.3174/ajnr.A1495. Epub 2009 Feb 12.
Zotero 插件